JP Morgan Private Wealth Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $623K | Buy |
|
|||||
|
2023
Q2 | $1.37M | Sell |
|
|||||
|
2023
Q1 | $1.8M | Buy |
|
|||||
|
2022
Q4 | $630K | Sell |
|
|||||
|
2022
Q3 | $1.01M | Buy |
|
|||||
|
2022
Q2 | $387K | Sell |
|
|||||
|
2022
Q1 | $1.66M | Sell |
|
|||||
|
2021
Q4 | $1.83M | Sell |
|
|||||
|
2021
Q3 | $4.6M | Buy |
|
|||||
|
2021
Q2 | $4.58M | Buy |
|
|||||
|
2021
Q1 | $2.3M | Buy |
|
|||||
|
2020
Q4 | $1.25M | Sell |
|
|||||
|
2020
Q3 | $1.27M | Sell |
|
|||||
|
2020
Q2 | $1.33M | Buy |
|
|||||
|
2020
Q1 | $479K | Buy |
|
|||||
|
2019
Q4 | $298K | Buy |
|
|||||
|
2019
Q3 | $190K | Buy |
|
|||||
|
2019
Q2 | $143K | Buy |
|